Details
Title
Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria
Author
Xue, Yibo 1
; Morris, Jordan L. 2
; Yang, Kangning 3
; Fu, Zheng 3 ; Zhu, Xianbing 3 ; Johnson, Fraser 4 ; Meehan, Brian 5 ; Witkowski, Leora 6
; Yasmeen, Amber 7 ; Golenar, Tunde 3 ; Coatham, Mackenzie 8 ; Morin, Geneviève 3 ; Monast, Anie 3 ; Pilon, Virginie 3 ; Fiset, Pierre Olivier 9 ; Jung, Sungmi 9 ; Gonzalez, Anne V. 10 ; Camilleri-Broet, Sophie 9
; Fu, Lili 9 ; Postovit, Lynne-Marie 11 ; Spicer, Jonathan 12
; Gotlieb, Walter H. 7 ; Guiot, Marie-Christine 13 ; Rak, Janusz 5
; Park, Morag 3
; Lockwood, William 4
; Foulkes, William D. 14
; Prudent, Julien 2
; Huang, Sidong 3
1 McGill University, Department of Biochemistry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Rosalind and Morris Goodman Cancer Research Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Human Genetics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Division of Medical Genetics, McGill University Health Centre, and Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
2 University of Cambridge, Medical Research Council Mitochondrial Biology Unit, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
3 McGill University, Department of Biochemistry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Rosalind and Morris Goodman Cancer Research Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
4 British Columbia Cancer Agency, Department of Integrative Oncology, Vancouver, Canada (GRID:grid.248762.d) (ISNI:0000 0001 0702 3000); University of British Columbia, Interdisciplinary Oncology Program, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830); University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830)
5 McGill University, Department of Pediatrics, Research Institute of the McGill University Health Centre, Montreal Children’s Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
6 McGill University, Department of Human Genetics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Specialized Medicine, Lady Davis Institute, Jewish General Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
7 McGill University, Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
8 University of Alberta, Department of Oncology, Department of Obstetrics and Gynecology, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
9 McGill University Health Centre, Department of Pathology, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811)
10 Montreal Chest Institute, Department of Medicine, Division of Respiratory Medicine, McGill University Health Centre, Montreal, Canada (GRID:grid.416229.a) (ISNI:0000 0004 0646 3575)
11 University of Alberta, Department of Oncology, Department of Obstetrics and Gynecology, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); Queen’s University, Department of Biomedical and Molecular Sciences, Kingston, Canada (GRID:grid.410356.5) (ISNI:0000 0004 1936 8331)
12 McGill University Health Center, Department of Surgery, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811)
13 McGill University Health Centre, Department of Pathology, Montreal Neurological Hospital/Institute, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811)
14 McGill University, Department of Human Genetics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Division of Medical Genetics, McGill University Health Centre, and Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Specialized Medicine, Lady Davis Institute, Jewish General Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
; Morris, Jordan L. 2
; Yang, Kangning 3
; Fu, Zheng 3 ; Zhu, Xianbing 3 ; Johnson, Fraser 4 ; Meehan, Brian 5 ; Witkowski, Leora 6
; Yasmeen, Amber 7 ; Golenar, Tunde 3 ; Coatham, Mackenzie 8 ; Morin, Geneviève 3 ; Monast, Anie 3 ; Pilon, Virginie 3 ; Fiset, Pierre Olivier 9 ; Jung, Sungmi 9 ; Gonzalez, Anne V. 10 ; Camilleri-Broet, Sophie 9
; Fu, Lili 9 ; Postovit, Lynne-Marie 11 ; Spicer, Jonathan 12
; Gotlieb, Walter H. 7 ; Guiot, Marie-Christine 13 ; Rak, Janusz 5
; Park, Morag 3
; Lockwood, William 4
; Foulkes, William D. 14
; Prudent, Julien 2
; Huang, Sidong 3
1 McGill University, Department of Biochemistry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Rosalind and Morris Goodman Cancer Research Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Human Genetics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Division of Medical Genetics, McGill University Health Centre, and Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
2 University of Cambridge, Medical Research Council Mitochondrial Biology Unit, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
3 McGill University, Department of Biochemistry, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Rosalind and Morris Goodman Cancer Research Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
4 British Columbia Cancer Agency, Department of Integrative Oncology, Vancouver, Canada (GRID:grid.248762.d) (ISNI:0000 0001 0702 3000); University of British Columbia, Interdisciplinary Oncology Program, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830); University of British Columbia, Department of Pathology and Laboratory Medicine, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830)
5 McGill University, Department of Pediatrics, Research Institute of the McGill University Health Centre, Montreal Children’s Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
6 McGill University, Department of Human Genetics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Specialized Medicine, Lady Davis Institute, Jewish General Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
7 McGill University, Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
8 University of Alberta, Department of Oncology, Department of Obstetrics and Gynecology, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X)
9 McGill University Health Centre, Department of Pathology, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811)
10 Montreal Chest Institute, Department of Medicine, Division of Respiratory Medicine, McGill University Health Centre, Montreal, Canada (GRID:grid.416229.a) (ISNI:0000 0004 0646 3575)
11 University of Alberta, Department of Oncology, Department of Obstetrics and Gynecology, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X); Queen’s University, Department of Biomedical and Molecular Sciences, Kingston, Canada (GRID:grid.410356.5) (ISNI:0000 0004 1936 8331)
12 McGill University Health Center, Department of Surgery, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811)
13 McGill University Health Centre, Department of Pathology, Montreal Neurological Hospital/Institute, Montreal, Canada (GRID:grid.63984.30) (ISNI:0000 0000 9064 4811)
14 McGill University, Department of Human Genetics, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Division of Medical Genetics, McGill University Health Centre, and Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649); McGill University, Department of Specialized Medicine, Lady Davis Institute, Jewish General Hospital, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
Pages
1552
Publication year
2023
Publication date
2023
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2789109389
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.